Table 1.

Clinical characteristics of study population.

HC (n=16) BPH (n=8) PCa (n=34) Omnibus p-value HC vs.BPH HC vs.PCa BPH vs.PCa
Age, years° 56.88 ± 11.35 64.38 ± 2.72 64.85± 5.04 0.002 n.s. 0.002 1
t-PSA, ng/ml* / 4.5 [1.5 – 8.5] 4 [3 – 7.25] / / / n.s.
f-PSA, ng/ml* / 1 [0.25 – 1] 0 [0 – 1] / / / n.s.
f-/PSA/t-PSA, %* / 20.5 [10.75 –34.5] 11 [7.75 – 17] / / / 0.038

Pathological Stage

T1 8 (23.5)
T2 17 (50)
T3 9 (26.5)

Gleason Sum

≤ 6 16 (47.0)
7 14 (41.2)
> 7 4 (11.8)

HC= Healthy Control; BPH=Benign Prostate Hyperplasia; PCa=Prostate Carcinoma; n.s.= non significant

° Data are expressed as mean ± standard deviation. Group comparison was based on ANOVA test followed by Bonferroni adjusted Student t test for unpaired samples.
*Data are expressed as median [25th–75th percentile]. Group comparison was based on Mann Whitney U test.
2014 July-September; 3(3): 89–95. ISSN: 2240-2594
Published online 2014 October 23.